MVZ für Hämatologie und Onkologie Ravensburg GmbH

Ravensburg 1 trials

1 Registered trials

0 Currently recruiting

Organisation

Location

Ravensburg, Germany

Identifier

ORL-000011687

Address

Elisabethenstr. 19, 88212, Germany

Departments

Clinical trials at this site (1)

Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23